tirzepatide vs semaglutide which is safer vs. For Weight Loss Compounded GLP-1 Safety: FDA Rules

Catecholamine responses were variable prior to the 45 mg/dL nadir, with no difference in adrenaline at nadir and during recovery from the nadir

Section 503B outsourcing facilities received a 90-day window that ended in March

If you bring lab work results to us from your own provider, they should be within the past few months and contain CBC, CMP, TSH, and HbA1C

Zepbound (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that is FDA-approved along with increased physical activity and a reduced-calorie diet for chronic weight management in adults with a starting body mass index (BMI) of: 30 kg/m^2 or higher (obesity) 27 kg/m^2 or higher (overweight) with at least one weight-related condition such as high cholesterol, high blood pressure (hypertension), type 2 diabetes, heart disease, or obstructive sleep apnea

Ask about the timeline for introducing both medications and what to expect during the adjustment period